This is the authors' abstract. We don't add key points for this paper.
Rifabutin is used in patients with human immunodeficiency virus infection to prevent and treat Mycobacterium avium complex infection. We report a case of recurrent bilateral anterior uveitis with hypopyon in a patient who was taking 600 mg of rifabutin daily. The rate of recurrence with the continuation of rifabutin seems to be high, especially in the opposite eye (alternate uveitis with hypopyon); rifabutin should be discontinued if uveitis recurs.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zénone et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: